If it was a snake oil con, the shorts would not be so busy on all the MB's and covering as they have.
I can't attest to all of that, now...
It does sound like JW was kind of shady, but with lots of charisma. I'm not a fan of car salesman, in general, either. The good thing is, whatever STSI/Anatabloc was based on -- legitimate, illegitimate, or quasi-legitimate science/business -- it is being transformed. Agreed that the new leadership seems like a big plus (that, and the low, low price {lol}, is why I bought in). I like that they have a product and revenue (unlike most small biotechs), notwithstanding the present hurdles as a result of that product. I don't like the synthetic route, but perhaps that is the only option when creating a pharmaceutical-grade product.
I think the con-man/snake oil thing is exaggerated, but then again, the same could be said about the aggrandizement on the bull side also. I'm assuming there are limited barriers to entry in the supplemental market (for anatabine compounds) if the product currently is as 'revolutionary' as some on this board contend. That is where my belief on its' 'subtlety' comes in. In it's current form taken properly (dosage-wise), it probably provides modest relief in general. If you are taking 20 or more pills a day, you are taking too much (there are other not so healthy ingredients in the pills, too). Thus the need for a more concentrated product However, risks will likely possibly increase as the 'drug' is made more potent (welcome to the world of biotech!).
The combo/cocktail angle for various indications is another logical and potentially lucrative direction. As we would say on the other biotech board when there was still hope, "it should be interesting"!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.